EDNRA and systemic sclerosis: In SSc patients, anti-AT1R and anti-ETAR ab levels were predictive for vascular complications such as pulmonary arterial hypertension (PAH) or digital ulcers [15–17, 19], but they were not able to predict deterioration of pulmonary fibrosis.